Alterity Therapeutics Ltd ADRATH
Price$3.65

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Free Cash Flow -$7.5MTTM through 30 Jun 2025

Margins

Current
Operating Margin-1,057.0%
Net Margin-6,038.5%

Returns

-26.9%ROE
-25.6%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio12.98x
Net Debt-$49.1Mnet cash position
Cash & Equivalents$33.2M

Quality Metrics

Piotroski F-Score4 / 9
FCF Margin-5,695.1%

Multi-Year Trend

Revenue
'16'17'18
FY2018: $201.2K
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $0.00

Dividend

No dividend

Capital Allocation

Capex Intensity4.3%
Financials converted at 1.5202 from AUD.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.